{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:29:58Z","timestamp":1789644598232,"version":"4.0.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02210-4","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:01:56Z","timestamp":1698782516000},"page":"927-936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-0258","authenticated-orcid":false,"given":"F.","family":"Fruzzetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fidecicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Benelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Baldari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tonacchera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2210_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D et al (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"2210_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"2210_CR3","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929\u20131935. https:\/\/doi.org\/10.1210\/jc.2004-1045","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A et al (2020) Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 26:942\u2013960. https:\/\/doi.org\/10.1093\/humupd\/dmaa029","journal-title":"Hum Reprod Update"},{"key":"2210_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/er.2012-1003","volume":"33","author":"HS Randeva","year":"2012","unstructured":"Randeva HS, Tan BK, Weickert MO et al (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 33:812\u2013841. https:\/\/doi.org\/10.1210\/er.2012-1003","journal-title":"Endocr Rev"},{"key":"2210_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/J.FERTNSTERT.2022.03.008","volume":"117","author":"K van der Ham","year":"2022","unstructured":"van der Ham K, Louwers YV, Laven JSE (2022) Cardiometabolic biomarkers in women with polycystic ovary syndrome. Fertil Steril 117:887\u2013896. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2022.03.008","journal-title":"Fertil Steril"},{"key":"2210_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.TCM.2019.08.010","volume":"30","author":"O Osibogun","year":"2020","unstructured":"Osibogun O, Ogunmoroti O, Michos ED (2020) Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc Med 30:399\u2013404. https:\/\/doi.org\/10.1016\/J.TCM.2019.08.010","journal-title":"Trends Cardiovasc Med"},{"key":"2210_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13795","author":"H Teede","year":"2018","unstructured":"Teede H, Misso M, Costello M et al (2018) International evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. https:\/\/doi.org\/10.1111\/cen.13795","journal-title":"Clin Endocrinol"},{"key":"2210_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/CLINEM\/DGAD463","volume":"00","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab 00:1\u201323. https:\/\/doi.org\/10.1210\/CLINEM\/DGAD463","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"key":"2210_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","volume":"92","author":"F Fruzzetti","year":"2009","unstructured":"Fruzzetti F, Perini D, Lazzarini V et al (2009) Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 92:626\u2013634. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.004","journal-title":"Fertil Steril"},{"key":"2210_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/JOG.12985","volume":"42","author":"E Bil","year":"2016","unstructured":"Bil E, Dilbaz B, Cirik DA et al (2016) Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype. J Obstet Gynaecol Res 42:837\u2013843. https:\/\/doi.org\/10.1111\/JOG.12985","journal-title":"J Obstet Gynaecol Res"},{"key":"2210_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6498768","volume":"2022","author":"A Biernacka-Bartnik","year":"2022","unstructured":"Biernacka-Bartnik A, Koce\u0142ak P, Owczarek AJ et al (2022) Prediction of insulin resistance and impaired fasting glucose based on sex hormone-binding globulin (SHBG) levels in polycystic ovary syndrome. Int J Endocrinol 2022:1\u20136. https:\/\/doi.org\/10.1155\/2022\/6498768","journal-title":"Int J Endocrinol"},{"key":"2210_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.641446","author":"V Di Stasi","year":"2021","unstructured":"Di Stasi V, Maseroli E, Rastrelli G et al (2021) SHBG as a marker of NAFLD and metabolic impairments in women referred for oligomenorrhea and\/or hirsutism and in women with sexual dysfunction. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.641446","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2210_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/J.METABOL.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N (2019) Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism 92:108\u2013120. https:\/\/doi.org\/10.1016\/J.METABOL.2018.11.002","journal-title":"Metabolism"},{"key":"2210_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","volume":"18","author":"AS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a AS, Witchel SF, Hoeger KM et al (2020) Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med 18:72. https:\/\/doi.org\/10.1186\/s12916-020-01516-x","journal-title":"BMC Med"},{"key":"2210_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"2210_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. https:\/\/doi.org\/10.1093\/clinchem\/18.6.499","journal-title":"Clin Chem"},{"key":"2210_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression. Chapter 5: assessing the fit of the model","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Chapter 5: assessing the fit of the model, 3rd edn. Wiley","edition":"3"},{"key":"2210_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3109\/09513590.2012.685205","volume":"28","author":"AD Genazzani","year":"2012","unstructured":"Genazzani AD, Prati A, Santagni S et al (2012) Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol 28:969\u2013973. https:\/\/doi.org\/10.3109\/09513590.2012.685205","journal-title":"Gynecol Endocrinol"},{"key":"2210_CR21","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0B013E3181EC173D","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5:1315\u20131316. https:\/\/doi.org\/10.1097\/JTO.0B013E3181EC173D","journal-title":"J Thorac Oncol"},{"key":"2210_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23084110","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23084110","journal-title":"Int J Mol Sci"},{"key":"2210_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R et al (2007) Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405\u2013413. https:\/\/doi.org\/10.1210\/jc.2006-1864","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1515\/CCLM.2007.031","volume":"45","author":"S Hahn","year":"2007","unstructured":"Hahn S, Kuehnel W, Tan S et al (2007) Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 45:5. https:\/\/doi.org\/10.1515\/CCLM.2007.031","journal-title":"Clin Chem Lab Med"},{"key":"2210_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/S-2006-924062","volume":"114","author":"A Mueller","year":"2006","unstructured":"Mueller A, Dittrich R, Cupisti S et al (2006) Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Exp Clin Endocrinol Diabetes 114:182\u2013187. https:\/\/doi.org\/10.1055\/S-2006-924062","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2210_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/S12872-021-02100-8","author":"B Zhang","year":"2021","unstructured":"Zhang B, Fan Y, Wang Y et al (2021) Comparison of bioelectrical body and visceral fat indices with anthropometric measures and optimal cutoffs in relation to hypertension by age and gender among Chinese adults. BMC Cardiovasc Disord. https:\/\/doi.org\/10.1186\/S12872-021-02100-8","journal-title":"BMC Cardiovasc Disord"},{"key":"2210_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-629","author":"P Liu","year":"2013","unstructured":"Liu P, Ma F, Lou H, Liu Y (2013) The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. https:\/\/doi.org\/10.1186\/1471-2458-13-629","journal-title":"BMC Public Health"},{"key":"2210_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.18502\/IJPH.V51I4.9246","volume":"51","author":"MH Almasi","year":"2022","unstructured":"Almasi MH, Barzin M, Serahati S et al (2022) Body composition assessment by bioelectrical impedance analysis in prediction of cardio-metabolic risk factors: Tehran lipid and glucose study (TLGS). Iran J Public Health 51:851\u2013859. https:\/\/doi.org\/10.18502\/IJPH.V51I4.9246","journal-title":"Iran J Public Health"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02210-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02210-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02210-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T01:23:39Z","timestamp":1711502619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02210-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2210"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02210-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"6 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards of the Committee on Institutional Human Experimentation, and with the Helsinki Declaration of 1975, as revised in 1983.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"All patients gave informed consent for data to be collected and for their anonymous data to be used for clinical publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}